“a verified decrease in CTCs would reliably predict shrinking or disappearing tumors. Moreover, I surmise that CYDY will reveal at ESMO that the CTC decreases demonstrated in 2021 during its Leronlimab clinical trial did exactly that.”

IMO opinion Jake, a verified decrease in CTCs has less to do with shrinking tumors, and much more to do with shrinking rates of metastasis. Once the Tumor Cells circulate in the bloodstream, they can take root in brain, liver, etc.

GL